Research Paper Volume 15, Issue 20 pp 10996—11011

Figure 2. Correlation between BTN2A2 expression and CFs. (A) BTN2A2 expression in patients with glioma in TCGA cohort. (B, C) BTN2A2 expression in patients with glioma in GEO cohort. (D) BTN2A2 expression in normal human astrocytes cells (NHA) and glioma cells (A172, T98G, LN229, and SF295) was determined using qRT-PCR. (E–G) Correlation between BTN2A2 expression and CFs (grade, IDH status, 1p/19q codeletion, age, primary therapeutic outcome, and histological type). ^*P < 0.05, ^**P < 0.01, ^***P < 0.001.